Form 4 · Filed Jun 17, 2026, 10:03 AM UTC
BLTE/BELITE BIO, INC
Scholl Hendrik Peter — Chief Medical Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
8 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | S | sell | 2,054 | $138 | $282,641 | 32,946 |
| Jun 16, 2026 | S | sell | 784 | $138 | $108,331 | 32,162 |
| Jun 16, 2026 | S | sell | 3,140 | $140 | $438,260 | 29,022 |
| Jun 16, 2026 | S | sell | 540 | $141 | $75,915 | 28,482 |
| Jun 16, 2026 | S | sell | 100 | $142 | $14,183 | 28,382 |
| Jun 16, 2026 | S | sell | 450 | $142 | $63,988 | 27,932 |
| Jun 16, 2026 | S | sell | 1,897 | $144 | $272,314 | 26,035 |
| Jun 16, 2026 | S | sell | 1,035 | $145 | $150,097 | 25,000 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-273321